"Maverix Medical...announced the acquisition of Cirrus Bio for an undisclosed amount....As part of the acquisition, Maverix also announced the formation of a dedicated diagnostic division called Maverix Dx that will develop, invest in, acquire, and bring to market a suite of diagnostic tools for lung cancer."